Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

23.88 -0.20 (-0.83%)

Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026

From Pfizer Inc.

Via Business Wire

Thriving in the Age of Overwhelm ↗

May 30, 2026

Why do so many people feel overwhelmed right now? And what can investors do about it?

Via The Motley Fool

Why Wall Street Is Dead Wrong About This Popular Stock ↗

May 30, 2026

Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.

Via The Motley Fool

Topics Intellectual Property

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026

From Pfizer Inc.

Via Business Wire

Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026

From Pfizer Inc.

Via Business Wire

Addiction Treatment Market Size, Demand, Growth By 2035 ↗

May 29, 2026

The most recent research report on the "Addiction Treatment Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts

Via Talk Markets

Topics Economy

Pfizer Strikes Up To $10.5 Billion Deal With China's Innovent Biologics To Develop Next-Gen Cancer Therapies ↗

May 29, 2026

Pfizer and Innovent Biologics sign a $10.5 billion cancer drug deal to develop 12 oncology programs globally.

Via Benzinga

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026

From Pfizer Inc.

Via Business Wire

Rituxan (rituximab) Drug Market Size, Share, Industry Growth By 2035 ↗

May 28, 2026

The most recent research report on the "Rituxan (rituximab) Drug Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic fore

Via Talk Markets

Topics Economy

Drugs for Oral Mucositis Market Size, Report Growth By 2035 ↗

May 28, 2026

The most recent research report on the "Drugs for Oral Mucositis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic fore

Via Talk Markets

Topics Economy

1 Stock Under $50 with Solid Fundamentals and 2 We Ignore

May 28, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

Via StockStory

Topics Energy

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026

From Pfizer Inc.

Via Business Wire

D-Wave Quantum vs. IonQ: Which Quantum Computing Stock Is a Better Buy in 2026? ↗

May 26, 2026

Explore how two quantum innovators stack up on customer reach, financial health, and risk as they race for commercial leadership in a fast-evolving sector.

Via The Motley Fool

3 Dividend Stocks Yielding Above 5% to Scoop Up Now

May 26, 2026

These three dividend stocks combine strong yields with resilient businesses.

Via Barchart.com

Topics Artificial Intelligence

3 Blue Chip Dividend Stocks to Buy in June as the Dow Jones Industrial Average Turns 130 ↗

May 26, 2026

The Dow is no longer dominated by industrial, energy, manufacturing, and consumer goods companies.

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe? ↗

May 25, 2026

The payout ratio is over 100% for this high-yield healthcare giant, but don't run for the hills just yet.

Via The Motley Fool

Topics Intellectual Property

Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38% ↗

May 25, 2026

As with other pharma companies, much rides on Pfizer's pipeline; it has many promising formulations in late-stage trials.

Via The Motley Fool

Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know. ↗

May 25, 2026

The pharma giant is taking steps to expand its portfolio.

Via The Motley Fool

Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1

May 24, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, incl...

Via StockStory

Topics Artificial Intelligence Intellectual Property

What's the Better Dividend Stock Today: AbbVie or Pfizer? ↗

May 24, 2026

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

Via The Motley Fool

Topics Intellectual Property

Is Relay Therapeutics a Buy After Promising Trial Results? ↗

May 22, 2026

Relay Therapeutics, a clinical-stage biotech, is getting a boost after positive trial news for its lead therapy.

Via The Motley Fool

The Most Important Healthcare Stock You're Not Watching ↗

May 22, 2026

Down more than 50% from its 2021 highs, this pharmaceutical giant has been forgotten by Wall Street.

Via The Motley Fool

Topics Intellectual Property

Pediatrics Medicine Market Size, Industry Report By 2035 ↗

May 22, 2026

The most recent research report on the "Pediatrics Medicine Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts

Via Talk Markets

Topics Economy

Prediction: Alphabet Will Join the $5 Trillion Club and the Dow Jones Industrial Average in June ↗

May 22, 2026

Honeywell is spinning off its aerospace segment, which could trigger a shake-up in the Dow Jones Industrial Average this summer.

Via The Motley Fool

Topics Stocks

May 22, 2026

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Via StockStory

2 Reasons to Watch PFE and 1 to Stay Cautious

May 22, 2026

Pfizer currently trades at $25.89 per share and has shown little upside over the past six months, posting a middling return of 2.7%. The stock also fell shor...

Via StockStory

Topics Supply Chain

The Most Undervalued Healthcare Stock in the S&P 500 Right Now ↗

May 21, 2026

The market appears to be short-sighted.

Via The Motley Fool

Topics Intellectual Property Stocks

2 Profitable Stocks Worth Your Attention and 1 We Find Risky

May 21, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

Topics Energy

Pfizer Expands Pneumococcal Vaccine Push With New Programs ↗

May 20, 2026

Pfizer reports Phase 2 infant vaccine data showing a stronger immune response against serotype 3 versus Prevnar 20.

Via Benzinga

How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise ↗

May 20, 2026

The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise topped its predecessor in a midstage study.

Via Investor's Business Daily

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.